Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer

被引:0
|
作者
Yingchun Zhao
Caishu Deng
Jiarui Wang
Jing Xiao
Zoran Gatalica
Robert R. Recker
Gary Guishan Xiao
机构
[1] Creighton University Medical Center,Genomics & Functional Proteomics Laboratories, Osteoporosis Research Center
[2] Creighton University Medical Center,Department of Pathology
来源
Breast Cancer Research and Treatment | 2011年 / 127卷
关键词
Let-7 family microRNAs; Breast cancer; FFPE; Estrogen receptor-α signaling;
D O I
暂无
中图分类号
学科分类号
摘要
In order to understand how microRNAs (miRNAs) regulate breast cancer tumorigenesis, a miRNA expression microarray screening was performed using RNA from formalin-fixed paraffin-embedded (FFPE) breast tissues, which included benign (n = 13), ductal carcinoma in situ (DCIS) (n = 16), and invasive ductal carcinoma (IDC) (n = 15). Twenty-five differentially expressed miRNAs (P < 0.01) were identified, of which let-7 family miRNAs were down-regulated in human breast cancer tissues at stages of DCIS and IDC compared to benign stage. We further found that there was an inverse correlation between ER-α expression and several members of let-7 family in the FFPE tissues. Next, we performed bioinformatics analysis and found that let-7 miRNA sequences match sequence in the 3′-UTR of estrogen receptor alpha (ER-α), suggesting ER-α may be a target of let-7, which was further confirmed by a number of experimental assays, including luciferase assay, protein expression, and mRNA expression. Overexpression of let-7 miRNAs in ER-positive breast cancer MCF7 cell line negatively affected ER-α activity. As expected, dampening of the ER-α signaling by let-7 miRNAs inhibited cell proliferation, and subsequently triggered the cell apoptotic process in MCF7 cells. In conclusion, our findings indicate a new regulatory mechanism of let-7 miRNAs in ER-α mediated cellular malignant growth of breast cancer.
引用
收藏
页码:69 / 80
页数:11
相关论文
共 50 条
  • [41] ZBTB7A governs estrogen receptor alpha expression in breast cancer
    Molloy, Mary Ellen
    Lewinska, Monika
    Williamson, Amanda K.
    Thanh Thao Nguyen
    Kuser-Abali, Gamze
    Gong, Lu
    Yan, Jiawei
    Little, John B.
    Pandolfi, Pier Paolo
    Yuan, Zhi-Min
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2018, 10 (04) : 273 - 284
  • [42] Schisandrol A Exhibits Estrogenic Activity via Estrogen Receptor α-Dependent Signaling Pathway in Estrogen Receptor-Positive Breast Cancer Cells
    Lee, Dahae
    Kim, Young-Mi
    Chin, Young-Won
    Kang, Ki Sung
    PHARMACEUTICS, 2021, 13 (07)
  • [43] Osteolytic effects of tumoral estrogen signaling in an estrogen receptor-positive breast cancer bone metastasis model
    Cheng, Julia N.
    Frye, Jennifer B.
    Whitman, Susan A.
    Kunihiro, Andrew G.
    Brickey, Julia A.
    Funk, Janet L.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2021, 7
  • [44] Citrus polymethoxyflavones degrade estrogen receptor-alpha (ERα) and combine with tamoxifen for the treatment of estrogen receptor-positive breast cancer
    Wang, Yiyu
    Sun, Meng
    He, Zhong
    Han, Ying
    Song, Yinhong
    Liang, Jianjia
    Wang, Huimin
    Qin, Ye
    Deng, Zhangshuang
    HELIYON, 2024, 10 (12)
  • [45] Estrogen receptor gene fusions drive endocrine therapy resistance in estrogen receptor positive breast cancer
    Lei, Jonathan T.
    Shao, Jieya
    Zhang, Jin
    Iglesia, Michael
    Chan, Doug W.
    Matsunuma, Ryoichi
    He, Xiaping
    Singh, Purba
    Kosaka, Yoshimasa
    Crowder, Robert
    Haricharan, Svasti
    Kavuri, Shyam
    Hoog, Jeremy
    Phommaly, Chanpheng
    Goncalves, Rodrigo
    Romalho, Susana
    Lai, Wei-Chu
    Hampton, Oliver
    Rogers, Anna
    Tobias, Ethan
    Parikh, Poojan
    Davies, Sherri
    Ma, Cynthia
    Suman, Vera
    Hunt, Kelly
    Watson, Mark
    Hoadley, Katherine A.
    Thompson, Aubrey
    Perou, Charles
    Creighton, Chad J.
    Maher, Chris
    Ellis, Matthew J.
    CANCER RESEARCH, 2017, 77
  • [46] Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer
    Goldberg, Jonathan
    Qiao, Na
    Guerriero, Jennifer L.
    Gross, Brett
    Meneksedag, Yagiz
    Lu, Yoshimi F.
    Philips, Anne V.
    Rahman, Tasnim
    Meric-Bernstam, Funda
    Roszik, Jason
    Chen, Ken
    Jeselsohn, Rinath
    Tolaney, Sara M.
    Peoples, George E.
    Alatrash, Gheath
    Mittendorf, Elizabeth A.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (02): : 496 - 504
  • [47] Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
    Datta, Jharna
    Willingham, Natalie
    Manouchehri, Jasmine M.
    Schnell, Patrick
    Sheth, Mirisha
    David, Joel J.
    Kassem, Mahmoud
    Wilson, Tyler A.
    Radomska, Hanna S.
    Coss, Christopher C.
    Bennett, Chad E.
    Ganju, Ramesh K.
    Sardesai, Sagar D.
    Lustberg, Maryam
    Ramaswamy, Bhuvaneswari
    Stover, Daniel G.
    Cherian, Mathew A.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Estrogen Receptor α Regulates ATM Expression through miRNAs in Breast Cancer
    Guo, Xiaojing
    Yang, Chunying
    Qian, Xiaolong
    Lei, Ting
    Li, Yaqing
    Shen, Haifa
    Fu, Li
    Xu, Bo
    CLINICAL CANCER RESEARCH, 2013, 19 (18) : 4994 - 5002
  • [49] Estrogen receptor β and breast cancer
    Balfe, PJ
    McCann, AH
    Welch, HM
    Kerin, MJ
    EJSO, 2004, 30 (10): : 1043 - 1050
  • [50] Estrogen receptor and breast cancer
    Sommer, S
    Fuqua, SAW
    SEMINARS IN CANCER BIOLOGY, 2001, 11 (05) : 339 - 352